Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-21-001785
Filing Date
2021-02-03
Accepted
2021-02-02 21:41:27
Documents
14
Period of Report
2021-01-29
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A mbrx20210202_8ka.htm   iXBRL 8-K/A 55418
6 mbrx20210202_8kaimg001.jpg GRAPHIC 3620
  Complete submission text file 0001437749-21-001785.txt   216448

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20210129.xsd EX-101.SCH 3699
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20210129_def.xml EX-101.DEF 13120
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20210129_lab.xml EX-101.LAB 17624
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20210129_pre.xml EX-101.PRE 13494
7 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20210202_8ka_htm.xml XML 2978
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37758 | Film No.: 21583997
SIC: 2834 Pharmaceutical Preparations